Text and Data Mining valid from 2017-11-15
Received: 3 May 2017
Accepted: 19 September 2017
First Online: 15 November 2017
: Drs Ehinger, Hansson, and Elmér and Åsander Frostner have equity interests in, and/or have received salary support from NeuroVive Pharmaceutical AB, a public company developing pharmaceuticals in the field of mitochondrial medicine. The other authors declare no financial or commercial conflict of interest.